CANCER REGISTRATION IN NORTH AFRICA. Mokhtar Hamdi Cherif

Transcription

1 CANCER REGISTRATION IN NORTH AFRICA Mokhtar Hamdi Cherif

2 Importance of Cancer Registration in North Africa Cancer is becoming a major problem of public health in North Africa cancer registries have become indispensable tools for information system and planning The three Maghreb countries have national strategic plans against cancer

3 CANCER REGISTRIES IN NORTH AFRICA 5 Alger 4 Blida Oran Medea Tlemcen Boumerdes Saida Mostaganem 10 Setif Batna CNE Bejaia Jijel Annaba Biskra BBA Guelma El Tarf

4 MATERIEL AND METHOD -The Three Maghreb Cancer Registries use the CANREG 5 software, provided and updated by IARC The Data collection is done by active mode -In Algeria The Setif Cancer Registry uses for the The Data Analysis (SEER * Stat) provided by the National Institute of Cancer of the USA. for Analysis of temporal trends cancer Join Point

5 ALGERIA

6 In Algeria, The New Challenge National Cancer Registration

7 IMPLEMENTATION OF NATIONAL NETWORK OF CANCER REGISTRIES Presidential Project National Cancer Plan Ministry of Health Strategic axis 6 Institutionalization of cancer registries

8 MAIN OBJECTIVE Cover 50 % of valited cancer registration in the national population at 31th December 2014.

9 INTERMEDIATE OBJECTIVES Implementation of new departmental cancer registries Consolidate existing registries Establishment of a network of cancer registries by region Establishment of a national coordination of regional networks Periodic evaluation of registration activities annual publication of local,regional and national incidence data Promote publications in CI5 Feed back information to different data sources

10 PRELIMINARY RESULTS OF THE EAST REGION NETWORK CANCER REGISTRIES - Target population: inhabitants implemented registries validated registries Covered Population inhabitants inhabitants Covered Rate 88% 57%

11 PRELIMINARY RESULTS OF THE WESTERN REGION NETWORK CANCER REGISTRIES - Target population: inhabitants implemented registries validated registries Covered Population inhabitants inhabitants Covered Rate 82 % 38%

12 PRELIMINARY RESULTS OF THE CENTRAL REGION NETWORK CANCER REGISTERS - Target population: inhabitants implemented registries validated registries Covered Population inhabitants inhabitants Covered Rate 75 % 57 %

13 PRELIMINARY RESULTS OF NATIONAL NETWORK CANCER REGISTRIES - Target population: inhabitants implemented registries Covered Population inhabitants Covered Rate 82 % -. validated registries inhabitants 52 %

14 National estimation based on validated registries at December 31, 2014 Number of cases Crude rate ASR Men Women Total

15 Incidence of the Main Sites in Algeria, in men, 2014 Sites Crude Rate /100,000 ASR (WR)/100,000 Median age Lung and Bronchus Colo-rectum Bladder Prostate Stomach 4,7 6,1 61 NPC Non-Hodgkin Lymphoma 4,3 5,4 57 Larynx 3,0 4,3 63 Leukaemia 2,8 3,8 41

16 Incidence of the Main Sites in Algeria, in women, 2014 Sites Crude Rate /100,000 ASR (WR)/100,000 Median age Breast Colo-rectum Cervix Thyroid Non-Hodgkin Lymphoma Stomach 3,7 4,7 56 gallbladder Leukaemia 3,1 4,2 39

17 Trend of the main sites Setif Cancer Registry, Algeria

18 Trends of the main sites man , Setif,Algeria

19 Trends of the main sites women , Setif,Algeria IC-95%= (2,0; 3,3)

20 ab: Trends of the main sites in men , Setif Sites APC IC-95% Trends Lung and Bronchus +0.6* (-0.5 ; 1.8) Colo-rectum +5.7* (4.3 ; 7.2) Stomach -2,1* (-2.8 ;-1,4) non-hodgkin lymphoma +2,24 (0,6 ; 3,9) Bladder +5,6* (3,6 ; 7,8) Prostate +4,4* (3.0 ; 5.9) Larynx +1,2* (-1,5 ; 4,1) NPC -0.1 (-1,6 ; 1,4)

21 ab: Trends of the main sites in women , Setif Sites APC IC-95% Trends Breast +6,5* (5,5 ; 7,5) Cervix -2,3* (-3,6 ; - 1) Lung and bronchus +2.5* (0.5 ; 5,0) Colo-rectum +5,5* (3,9 ; 7,1) Stomach -0,5* (-2,0 ; 1,0) non-hodgkin lymphoma +3,3* (1,8 ; 4,8) Thyroid +8,6* (6,5 ; 10,9) Gallbladder -2,0* (-4,0 ; 0,1)

22

23

24 Annual projections of the number of cancer cases in Algeria Femme Homme

25 TUNISIA

26 TUNISIA CANCER REGISTRIES Target Population: Inhabitants Covered Population: Inhabitants Covered rate : 60% Rates / Inhabitants Crude Rate ASR Male 122,5 129,9 Female 98,4 99,7

27 MOROCCO

28 MOROCCO CANCER REGISTRIES Target Population: Inhabitants Covered Population: Inhabitants Covered rate : 18% Rates / Inhabitants Crude Rate ASR Male 112,5 132,8 Female 119,8 121,9

29 LIBYA CANCER REGISTRY Target Population: Inhabitants Covered Population: Inhabitants Covered rate : 22 % Rates / Inhabitants Crude Rate ASR Male 74,8 138,5 Female

30 COMPARISON OF COVERED POPULATION BY CANCER REGISTRATION IN NORTH AFRICA COUNTRY GENERAL POPULATION COVERED POPULATION COVERED RATE ALGERIA % TUNISIA % MOROCCO % LIBYA %

31 Comparison of ASR in North Africa Algeria Tunisia Morocco Lybia Men ,9 132,8 138,5 Women ,7 121,9 110,0 Total ,8 127,4 124,3

32 Comparison OF ASR(WR)/100,000 of main sites in Men in North Africa Sites Algeria (National Network) Tunisia (North) Morocco (Casablanca) Libya (Benghazi) Lung and Bronchus ,6 25,9 27,8 Colo-rectum ,5 8,1 13,8 Bladder ,9 8,7 14,9 Prostate ,4 13,5 14,7 Stomach 6,1 5,8 4,8 4,9 NPC 5.9 3,5 4,2 2,8 Non-Hodgkin Lymphoma 5,4 5,7 7,2 5,8 Larynx 4,3 6,0 6,1 5,5 Leukaemia 3,8 3,6 2,7 4,8

33 Comparison OF ASR(WR)/100,000 of main sites in Women in North Africa Sites Algeria (National Network) Tunisia (North) Morocco (Casablanca) Libya (Benghazi) Breast ,9 36,4 22,9 Colo-rectum ,2 5,8 12,3 Cervix ,6 15 4,5 Thyroid 8.1 3,3 6,7 3,8 Non-Hodgkin Lymphoma 4.9 3,8 4,7 4,3 Estomac 4,7 3,2 2,7 3,0 Gallbladder 4.5 2,6 1,9 3,2 Leukaemia 4,2 2,8 2,0 4,8

34 REGISTRIES VALIDATED BY IARC WITH PUBLICATION IN CI5 (CANCER INCIDENCE IN FIVE CONTINENTS) IN NORTH AFRICA Volumes CI5 VI CI5 VII CI5 VIII CI5 IX CI5 X Total Algeria Setif Setif Algiers Setif Setif 5 Tunisia Sousse North 2 Morocco LIBYA Benghazi 1

35 HOPE Algeria

36 CONCLUSION Cancer registration in North Africa has become a priority for Health Systems in Algeria, Morocco and Tunisia Cancer registries are now formalized and institutionalized The coverage of cancer registration is clearly increasing in North Africa We begin to have a completeness and good quality of cancer incidence data The incidence data for Maghreb countries compared with industrialized countries remain relatively low,but have increased significantly over the last years Comparison of the incidence data in the three Maghreb countries does not show large differences